TREATMENT OF SKELETAL METASTASES FROM UROLOGIC MALIGNANCIES.GRANT TT; DEKERNION JB.1978; UROLOGY; USA; DA. 1978; VOL. 11; NO 6; PP. 563-567; BIBL. 10 REF.Article

BCG-INDUCED ENHANCEMENT OF TUMOR GROWTH IN EXPERIMENTAL BLADDER TUMOR MODELKATSUOKA Y; DEKERNION JB.1982; TOKAI JOURNAL OF EXPERIMENTAL AND CLINICAL MEDICINE; ISSN 0385-0005; JPN; DA. 1982; VOL. 7; NO 4; PP. 481-487; BIBL. 15 REF.Article

IMMUNE RNA THERAPY FOR RENAL CELL CARCINOMA: SURVIVAL AND IMMUNOLOGIC MONITORING.RAMMING KP; DEKERNION JB.1977; ANN. SURG.; U.S.A.; DA. 1977; VOL. 186; NO 4; PP. 459-467; BIBL. 17 REF.Article

COST-EFFECTIVE ANALYSIS OF PRE-CYSTECTOMY RADIOISOTOPE SCANS = ANALYSE COUT-EFFICACITE DE LA SCINTIGRAPHIE AVANT CYSTECTOMIELINDNER A; DEKERNION JB.1982; JOURNAL OF UROLOGY; ISSN 0022-5347; USA; DA. 1982; VOL. 128; NO 6; PP. 1181-1182; ABS. ENG; BIBL. 8 REF.Article

THE RESPONSE OF METASTATIC RETROPERITONEAL SEMINOMA TO CHEMOTHERAPY.DEKERNION JB; LUPU AN.1977; J. UROL.; U.S.A.; DA. 1977; VOL. 117; NO 6; PP. 736-738; BIBL. 9 REF.Article

MANAGEMENT OF ADVANCED TESTICULAR SEMINOMASMITH RB; DEKERNION JB; SKINNER DG et al.1979; J. UROL.; USA; DA. 1979; VOL. 121; NO 4; PP. 429-431; BIBL. 38 REF.Article

IMMUNE CYTOLYSIS OF HUMAN RENAL CARCINOMA MEDIATED BY XENOGENEIC IMMUNE RIBONUCLEIC ACIDBROWER PA; DEKERNION JB; RAMMING KP et al.1976; J. UROL.; U.S.A.; DA. 1976; VOL. 115; NO 3; PP. 243-245; BIBL. 11 REF.Article

TREATMENT OF ADVANCED SEMINOMA WITH PRE-RADIATION CHEMOTHERAPY = TRAITEMENT DES SEMINOMES AVANCES PAR CHIMIOTHERAPIE AVANT LA RADIOTHERAPIECRAWFORD ED; SMITH RB; DEKERNION JB et al.1983; JOURNAL OF UROLOGY; ISSN 0022-5347; USA; DA. 1983; VOL. 129; NO 4; PP. 752-756; ABS. ENG; BIBL. 13 REF.; GRAPH, FIGArticle

VIRUS-INDUCED GENITOURINARY MALIGNANCY. MACROMOLECULAR IDENTITY = TUMEURS MALIGNES DES VOIES GENITO-URINAIRES INDUITES PAR VIRUS. IDENTITE DES MACROMOLECULESPAULSON DF; FRALEY EE; DEKERNION JB et al.1973; INVEST. UROL.; U.S.A.; DA. 1973; VOL. 10; NO 4; PP. 298-304; BIBL. 21REF.Serial Issue

UNUSUAL CASE OF URETHRAL CARCINOMAANGEL JR; KRAUS SD; MCCLUNG T et al.1981; UROLOGY (RIDGEWOOD); ISSN 0090-4295; USA; DA. 1981; VOL. 18; NO 1; PP. 74-77; BIBL. 13 REF.Article

IMMUNOTHERAPY FOR MALIGNANT LESIONS IN MAN USING IMMUNOGENIC RIBONUCLEIC ACID = IMMUNOTHERAPIE POUR LESIONS MALIGNES CHEZ L'HOMME EN UTILISANT DE L'ACIDE RIBONUCLEIQUE IMMUNOGENEDEKERNION JB; RAMMING KP; BROWER P et al.1975; AMER. J. SURG.; U.S.A.; DA. 1975; VOL. 130; NO 5; PP. 575-578; BIBL. 11 REF.Article

FAILURE OF ASCORBIC ACID TO INHIBIT FANFT-INDUCED BLADDER CANCER = ECHEC DE L'ACIDE ASCORBIQUE A INHIBER LE CANCER DE LA VESSIE PROVOQUE PAR FANFTSOLOWAY MS; COHEN SM; DEKERNION JB et al.1975; J. UROL.; U.S.A.; DA. 1975; VOL. 113; NO 4; PP. 483-486; BIBL. 25REF.Article

RISK OF URINARY INCONTINENCE FOLLOWING RADICAL PROSTATECTOMY = RISQUES D'INCONTINENCE URINAIRE APRES PROSTATECTOMIE RADICALELINDNER A; DEKERNION JB; SMITH RB et al.1983; JOURNAL OF UROLOGY; ISSN 0022-5347; USA; DA. 1983; VOL. 129; NO 5; PP. 1007-1008; ABS. ENG; BIBL. 8 REF.Article

SERUM-FREE MEDIUM FOR THE IN VITRO GROWTH OF NORMAL AND MALIGNANT URINARY BLADDER EPITHELIAL CELLSMESSING EM; FAHEY JL; DEKERNION JB et al.1982; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 6; PP. 2392-2397; BIBL. 22 REF.Article

ACUTE EFFECTS OF ORALLY ADMINISTERED LEVAMISOLE ON RANDOM MONOCYTE MOTILITY AND CHEMOTAXIS IN MANNATHANSON SD; ZAMFIRESCU PL; PORTARO JK et al.1978; J. NATION. CANCER INST.; USA; DA. 1978; VOL. 61; NO 2; PP. 301-306; BIBL. 41 REF.Article

SUCCESSFUL TRANSURETHRAL INTRALESIONAL BCG THERAPY OF A BLADDER MELANOMADEKERNION JB; GOLUB SH; GUPTA RK et al.1975; CANCER; U.S.A.; DA. 1975; VOL. 36; NO 5; PP. 1662-1667; BIBL. 15 REF.Article

A COMPARISON OF ESTRAMUSTINE PHOSPHATE VERSUS CIS-PLATINUM ALONE VERSUS ESTRAMUSTINE PHOSPHATE PLUS CIS-PLATINUM IN PATIENTS WITH ADVANCED HORMONE REFRACTORY PROSTATE CANCER WHO HAD HAD EXTENSIVE IRRADIATION TO THE PELVIS OR LUMBOSACRAL AREA = UNE COMPARAISON DU PHOSPHATE D'ESTRAMUSTINE ET DU CIS-PLATINUM SEUL ET DU PHOSPHATE D'ESTRAMUSTINE ASSOCIE AU CIS-PLATINUM CHEZ LES SUJETS AYANT UN CANCER AVANCE DE LA PROSTATE HORMONORESISTANT AYANT SUBI UNE IRRADIATION ETENDUE DU PETIT BASSIN OU DE LA REGION LOMBOSACREESOLOWAY MS; BECKLEY S; BRADY MF et al.1983; JOURNAL OF UROLOGY; ISSN 0022-5347; USA; DA. 1983; VOL. 129; NO 1; PP. 56-61; ABS. ENG; BIBL. 15 REF.; GRAPHArticle

THE ADDITION OF CHEMOTHERAPY TO HORMONAL THERAPY FOR TREATMENT OF PATIENT WITH METASTATIC CARCINOMA OF THE PROSTATE = L'ADJONCTION D'UNE CHIMIOTHERAPIE A L'HORMONOTHERAPIE DANS LE TRAITEMENT DU CANCER METASTATIQUE DE LA PROSTATEGIBBONS RP; BECKLEY S; BRADY MF et al.1983; JOURNAL OF SURGICAL ONCOLOGY; ISSN 0022-4790; USA; DA. 1983; VOL. 23; NO 2; PP. 133-142; ABS. ENG; BIBL. 22 REF.; GRAPHArticle

COMPARISON OF ESTRAMUSTINE PHOSPHATE, METHOTREXATE AND CIS-PLATINUM IN PATIENTS WITH ADVANCED, HORMONE REFRACTORY PROSTATE CANCER = COMPARAISON ENTRE LE PHOSPHATE D'ESTRAMUSTINE, LE METHOTREXATE ET LE CIS-PLATINUM CHEZ LES SUJETS AYANT UN CANCER AVANCE DE LA PROSTATE HORMONORESISTANTLOENING SA; BECKLEY S; BRADY MF et al.1983; JOURNAL OF UROLOGY; ISSN 0022-5347; USA; DA. 1983; VOL. 129; NO 5; PP. 1001-1006; ABS. ENG; BIBL. 25 REF.; GRAPHConference Paper

TREATMENT OF NEWLY DIAGNOSED METASTATIC PROSTATE CANCER PATIENTS WITH CHEMOTHERAPY AGENTS IN COMBINATION WITH HORMONES VERSUS HORMONES ALONE = TRAITEMENT DU CANCER METASTATIQUE DE LA PROSTATE RECEMMENT DIAGNOSTIQUE PAR CHIMIOHORMONOTHERAPIE COMPAREE AVEC L'HORMONOTHERAPIE SEULEMURPHY GP; BECKLEY S; BRADY MF et al.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 7; PP. 1264-1272; ABS. ENG; BIBL. 17 REF.; GRAPHArticle